Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1989 Jan 14;298(6666):65–66. doi: 10.1136/bmj.298.6666.65

Causes of the haemolytic uraemic syndrome.

J Kavi 1, R Wise 1
PMCID: PMC1835439  PMID: 2493295

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carter A. O., Borczyk A. A., Carlson J. A., Harvey B., Hockin J. C., Karmali M. A., Krishnan C., Korn D. A., Lior H. A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home. N Engl J Med. 1987 Dec 10;317(24):1496–1500. doi: 10.1056/NEJM198712103172403. [DOI] [PubMed] [Google Scholar]
  2. Drummond K. N. Hemolytic uremic syndrome--then and now. N Engl J Med. 1985 Jan 10;312(2):116–118. doi: 10.1056/NEJM198501103120211. [DOI] [PubMed] [Google Scholar]
  3. Fong J. S., de Chadarevian J. P., Kaplan B. S. Hemolytic-uremic syndrome. Current concepts and management. Pediatr Clin North Am. 1982 Aug;29(4):835–856. doi: 10.1016/s0031-3955(16)34216-x. [DOI] [PubMed] [Google Scholar]
  4. Kaplan B. S., Proesmans W. The hemolytic uremic syndrome of childhood and its variants. Semin Hematol. 1987 Jul;24(3):148–160. [PubMed] [Google Scholar]
  5. Karmali M. A., Petric M., Lim C., Fleming P. C., Arbus G. S., Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis. 1985 May;151(5):775–782. doi: 10.1093/infdis/151.5.775. [DOI] [PubMed] [Google Scholar]
  6. Kavi J., Chant I., Maris M., Rose P. E. Cytopathic effect of verotoxin on endothelial cells. Lancet. 1987 Oct 31;2(8566):1035–1035. doi: 10.1016/s0140-6736(87)92609-2. [DOI] [PubMed] [Google Scholar]
  7. Koster F., Levin J., Walker L., Tung K. S., Gilman R. H., Rahaman M. M., Majid M. A., Islam S., Williams R. C., Jr Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N Engl J Med. 1978 Apr 27;298(17):927–933. doi: 10.1056/NEJM197804272981702. [DOI] [PubMed] [Google Scholar]
  8. Levin M., Barratt J. M. Haemolytic uraemic syndrome. Arch Dis Child. 1984 May;59(5):397–400. doi: 10.1136/adc.59.5.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lingwood C. A., Law H., Richardson S., Petric M., Brunton J. L., De Grandis S., Karmali M. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem. 1987 Jun 25;262(18):8834–8839. [PubMed] [Google Scholar]
  10. Neill M. A., Tarr P. I., Clausen C. R., Christie D. L., Hickman R. O. Escherichia coli O157:H7 as the predominant pathogen associated with the hemolytic uremic syndrome: a prospective study in the Pacific Northwest. Pediatrics. 1987 Jul;80(1):37–40. [PubMed] [Google Scholar]
  11. O'Brien A. D., Holmes R. K. Shiga and Shiga-like toxins. Microbiol Rev. 1987 Jun;51(2):206–220. doi: 10.1128/mr.51.2.206-220.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. O'Brien A. D., LaVeck G. D., Thompson M. R., Formal S. B. Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. J Infect Dis. 1982 Dec;146(6):763–769. doi: 10.1093/infdis/146.6.763. [DOI] [PubMed] [Google Scholar]
  13. O'Brien A. O., Lively T. A., Chen M. E., Rothman S. W., Formal S. B. Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin. Lancet. 1983 Mar 26;1(8326 Pt 1):702–702. doi: 10.1016/s0140-6736(83)91987-6. [DOI] [PubMed] [Google Scholar]
  14. Obrig T. G., Del Vecchio P. J., Karmali M. A., Petric M., Moran T. P., Judge T. K. Pathogenesis of haemolytic uraemic syndrome. Lancet. 1987 Sep 19;2(8560):687–687. doi: 10.1016/s0140-6736(87)92473-1. [DOI] [PubMed] [Google Scholar]
  15. Olsnes S., Reisbig R., Eiklid K. Subunit structure of Shigella cytotoxin. J Biol Chem. 1981 Aug 25;256(16):8732–8738. [PubMed] [Google Scholar]
  16. Rose P. E., Armour J. A., Williams C. E., Hill F. G. Verotoxin and neuraminidase induced platelet aggregating activity in plasma: their possible role in the pathogenesis of the haemolytic uraemic syndrome. J Clin Pathol. 1985 Apr;38(4):438–441. doi: 10.1136/jcp.38.4.438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rose P. E., Enayat S. M., Sunderland R., Short P. E., Williams C. E., Hill F. G. Abnormalities of factor VIII related protein multimers in the haemolytic uraemic syndrome. Arch Dis Child. 1984 Dec;59(12):1135–1140. doi: 10.1136/adc.59.12.1135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Scotland S. M., Rowe B., Smith H. R., Willshaw G. A., Gross R. J. Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes. J Med Microbiol. 1988 Apr;25(4):237–243. doi: 10.1099/00222615-25-4-237. [DOI] [PubMed] [Google Scholar]
  19. Taylor C. M., White R. H., Winterborn M. H., Rowe B. Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands. Br Med J (Clin Res Ed) 1986 Jun 7;292(6534):1513–1516. doi: 10.1136/bmj.292.6534.1513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. White D. J., Yong F., McKendrick M. W. Haemolytic uraemic syndrome in adults. Br Med J (Clin Res Ed) 1988 Mar 26;296(6626):899–899. doi: 10.1136/bmj.296.6626.899. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES